Skip to content
10-Q

Quarterly Report

ANIXA BIOSCIENCES, INC. ANIX

0001641172-25-012701

← back to feed
Filed
May 28, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · May 28, 2025 32.21M sh
Stock Issued Q2 2025 · Apr 30, 2025 14.71K sh
Short Term Investments Q2 2025 · Apr 30, 2025 $13.69M
Short Term Investments Q2 2025 · Oct 31, 2024 $18.65M
Cash And Equivalents Q2 2025 · Apr 30, 2025 $1.91M
Cash And Equivalents Q2 2025 · Oct 31, 2024 $1.27M
Stockholders Equity Q2 2025 · Apr 30, 2025 $16.07M
Stockholders Equity Q2 2025 · Oct 31, 2024 $20M
Current Liabilities Q2 2025 · Apr 30, 2025 $1.89M
Current Liabilities Q2 2025 · Oct 31, 2024 $2.5M
Total Liabilities Q2 2025 · Apr 30, 2025 $2.07M
Total Liabilities Q2 2025 · Oct 31, 2024 $2.7M
Current Assets Q2 2025 · Apr 30, 2025 $16.77M
Current Assets Q2 2025 · Oct 31, 2024 $21.36M
Total Assets Q2 2025 · Apr 30, 2025 $16.98M
Total Assets Q2 2025 · Oct 31, 2024 $21.59M
Shares Diluted restated Q2 2025 · Apr 30, 2024 31.91M sh
Shares Diluted restated Q2 2025 · Apr 30, 2024 31.68M sh
Operating Cash Flow Q2 2025 · Apr 30, 2024 −$3.77M
Eps Diluted Q2 2025 · Apr 30, 2024 −$0.10
Eps Diluted Q2 2025 · Apr 30, 2024 −$0.20
Eps Basic Q2 2025 · Apr 30, 2024 −$0.10
Eps Basic Q2 2025 · Apr 30, 2024 −$0.20
Rd Expense Q2 2025 · Apr 30, 2024 $1.65M
Rd Expense Q2 2025 · Apr 30, 2024 $3M
Net Income Q2 2025 · Apr 30, 2024 −$3.14M
Net Income Q2 2025 · Apr 30, 2024 −$6.39M
Operating Income Q2 2025 · Apr 30, 2024 −$3.47M
Operating Income Q2 2025 · Apr 30, 2024 −$7.08M